Coagulopathy as a Therapeutic Target for TRALI: Rationale and Possible Sites of Action

Current Pharmaceutical Design - United Arab Emirates
doi 10.2174/1381612811209023267
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Preclinical Rationale for TGF-β Inhibition as a Therapeutic Target for the Treatment of Myelofibrosis

Experimental Hematology
Cancer ResearchGeneticsHematologyMolecular BiologyCell Biology
2016English

A Possible Therapeutic Target for Lou Gehrig's Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2004English

LncRNA as a Therapeutic Target for Angiogenesis

Current Topics in Medicinal Chemistry
MedicineDrug Discovery
2017English

YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer’s Disease

Current Neuropharmacology
MedicinePsychiatryMental HealthNeurologyPharmacology
2017English

Modulation of Receptor Sensitivity: Possible Therapeutic Target?

British Journal of Pharmacology
Pharmacology
2009English

Lysosomes as a Therapeutic Target

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2019English

CD38 as a Therapeutic Target

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2006English

TIMP-3 as a Therapeutic Target for Cancer

Therapeutic Advances in Medical Oncology
Oncology
2019English

Irisin: As a Therapeutic Target for Metabolic Disorders

Journal of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy